Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 5:02 AM
Ignite Modification Date:
2025-12-26 @ 4:03 AM
NCT ID:
NCT04776018
Group ID:
EG004
Title:
Phase 1b, Part 1: TAK-981 120 mg QW + Mezagitamab 600 mg
Description:
Participants received TAK-981 120 mg, infusion, intravenously, in combination with mezagitamab 600 mg, injection, subcutaneously, once weekly on Days 1, 8, 15, 22 during Cycles 1 and 2, then every 2 weeks during Cycles 3 through 6, further once every 4 weeks until disease progression or unacceptable toxicity, or until any other discontinuation criterion is met, whichever occurs first. Each Cycle length was 28 days.
Deaths Number Affected:
4
Deaths Number At Risk:
None
Serious Number Affected:
3
Serious Number At Risk:
8
Other Number Affected:
8
Other Number At Risk:
8
Study:
NCT04776018
Results Section:
NCT04776018
Adverse Events Module:
NCT04776018